Dear Editor
After the first two months of the epidemics of Coronavirus Disease 2019 (COVID-19) in the world [1,2], caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), multiple epidemiological assessments in countries from Asia, Pacific, Europe, and North America have been published [3,4]. Nevertheless, there are countries, with a rapid increase and a high number of cases, with a lack of studies. This is the case of Iran in the Middle East. For these reasons, we have developed epidemiological maps of cases but also of incidence rates using official populations, by provinces, for COVID-19 in Iran using geographical information systems (GIS).
Surveillance cases data from February 19 to March 9, 2020, officially reported by the Iranian health authorities were used to estimate the cumulated incidence rates using reference population data on SARS-CoV-2 confirmed infections (cases/100,000 pop) and to develop the maps by provinces, using the GIS software Kosmo® 3.1.
During the first 20 days of epidemics, 7161 cases of COVID-19 were reported in the country, for a cumulated rate of 8.9 cases/100,000 population, reaching up to 1234 cases during March 6, 2020 (Fig. 1 ). All the provinces have been affected, and rates ranged from 0.8 (Boushehr) to 61.8 cases/100,000 population (Qom) (Fig. 1). At Qom, the first two cases were reported. COVID-19 arrived at Iran from China. The highest number of cases have been reported in Tehran, 1945 (Fig. 1), followed by Qom, 712, and by Mazandaran, with 633. Qom is the border with Markazi and Semnan, provinces with rates from 27.2 to 34.9 cases/100,000 population. From the GIS-based maps, it is clear that spreading in the country is occurring from north-central provinces such as Tehran and Qom. Till March 9, 2020, there have been 237 deaths (3.31%, case fatality rate). While the number of cases seems to decrease during the last three days, this is not occurring with fatalities (Fig. 1).
Fig. 1.
COVID-19 situation in Iran, February 19 to March 9, 2020. A. Number of cases and deaths. B. Case distribution by provinces. C. Incidence rates, cases/100,000 population by provinces.
Iran is the third country with the highest number of reported COVID-19 cases after China, and Italy, up to March 16, 2020 with 14,991 cases, being the first in the Middle East region, and maybe becoming a significant source of imported cases in this area, in countries such as Iraq, Afghanistan, and Pakistan, among others. While the highest number of COVID-19 cases has been reported in the capital city, using GIS and estimating the incidence/attack rates per province, that one is placed as the seventh, having more cases per population at Qom, Semnan, and Markazi, among other provinces (Fig. 1).
A recent study, based on imported cases from Iran, estimated that 18,300 (95% confidence interval: 3770 to 53,470) COVID-19 cases would have had to occur in the country [5], assuming an outbreak duration of 1.5 months. Even if it were considered that all imported cases of Iran were identified in all states with certainty, the “best case” outbreak size was substantial (1820, 95% CI: 380–5320 cases), and far higher than reported case counts in February 2020. All confirmed cases in Saudi Arabia are imported from Iran and one from Iraq and other cases are close contacts to those confirmed cases. Imported cases from Iran have been diagnosed at Kuwait, Bahrain, Iraq, Oman, Qatar, among other Asiatic countries, but also Georgia, Estonia, Belarus, and even New Zealand [6].
The capital city of Khorasan Razavi (3.1 cases/100,000 population), Mashhad, is the second-largest holy city in the world, attracting more than 20 million tourists and pilgrims every year [7,8], many of whom come to pay homage to the Imam Reza shrine (the eighth Shi'ite Imam).
Regardless of this epidemiological scenario, the Iran outbreak of COVID-19 is still beginning and complex. Authorities have limited travel, and schools and universities have closed, as also have occurred in Italy and Spain, until the start of the holiday for Persian new year Nowruz on March 20, 2020, as measures for spreading of this coronavirus [7].
As there are severe limitations in the medical supplies available in the Iranian public health system to deal with the current SARS-CoV-2 outbreak, international support, additionally to be provided from the World Health Organization, is needed in the country to mitigate the impacts of this epidemic, and to avoid additional spreading. For the moment of the proofs correction of this article, Iran reached 14,991 cases, of them 3,774 in Tehran, 1,301 in Esfahan, and 1,023 in Qom (March 16, 2020).
Credit
AJRM, Conceptualization; Data curation; Formal analysis; Methodology; Software; Writing - original draft; Writing - review & editing. ZAM, Data curation; Formal analysis; Methodology; Writing - review & editing. RS, Writing - review & editing. AAR, Writing - review & editing. KD, Writing - review & editing.
Declaration of competing interest
We declare that we have no competing interests.
References
- 1.Rodriguez-Morales A.J., MacGregor K., Kanagarajah S., Patel D., Schlagenhauf P. Going global - travel and the 2019 novel coronavirus. Trav Med Infect Dis. 2020;33 doi: 10.1016/j.tmaid.2020.101578. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Rodriguez-Morales A.J., Bonilla-Aldana D.K., Balbin-Ramon G.J., Paniz-Mondolfi A., Rabaan A., Sah R. History is repeating itself, a probable zoonotic spillover as a cause of an epidemic: the case of 2019 novel Coronavirus. Infezioni Med Le. 2020;28:3–5. [PubMed] [Google Scholar]
- 3.Bastola A., Sah R., Rodriguez-Morales A.J., Lal B.K., Jha R., Ojha H.C. The first 2019 novel coronavirus case in Nepal. Lancet Infect Dis. 2020;20:279–280. doi: 10.1016/S1473-3099(20)30067-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Dong E., Du H., Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020 doi: 10.1016/S1473-3099(20)30120-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Tuite A.R., Bogoch I., Sherbo R., Watts A., Fisman D.N., Khan K. Estimation of COVID-2019 burden and potential for international dissemination of infection from Iran. medRxiv. 2020 doi: 10.1101/2020.02.24.20027375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Wilson M.E., Chen L.H. Travelers give wings to novel coronavirus (2019-nCoV) J Trav Med. 2020 doi: 10.1093/jtm/taaa015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ebrahim S.H., Memish Z.A. COVID-19: preparing for superspreader potential among Umrah pilgrims to Saudi Arabia. Lancet. 2020;395(10227):e48. doi: 10.1016/S0140-6736(20)30466-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Ebrahim S.H., Memish Z.A. COVID-19 – the role of mass gatherings. Trav Med Infect Dis. 2020 doi: 10.1016/j.tmaid.2020.101617. [DOI] [PMC free article] [PubMed] [Google Scholar]